semaglutide for heart failure may help treat symptoms in type 2 diabetes Weight-loss drug Wegovy produces 'largest

These mechanisms contribute to the substantial weight loss observed in clinical trials, with patients in the STEP 1 trial losing an average of 14.9% of body weight (compared to 2.4% with placebo) on the 2.4 mg weekly dose used for obesity management

However, over time, the pancreas may become exhausted and unable to keep up with the demand for insulin, leading to type 2 diabetes.Insulin resistance is also associated with other metabolic abnormalities, including high levels of triglycerides and low levels of HDL cholesterol, a condition known as dyslipidemia

Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021)

Problems occur when overwhelming free radicals (oxidative stress) or toxic load depletes our glutathione stores, preventing us from protecting ourselves against cellular and mitochondrial damage, toxins, infections, or cancer

More than 80% of individuals with T2D are overweight or obese